American Herbal Products Association (AHPA) > News > AHPA Updates

AHPA Updates

Updates on AHPA activities and resources delivered to your inbox. Subscribe today!

ERB Foundation seeks matching funds to sponsor ginseng program at 2020 Smithsonian Folklife Festival

ERB Foundation seeks matching funds to sponsor ginseng program at 2020 Smithsonian Folklife Festival

June 24-28 and July 1-5, 2020 -- Washington, DC

The AHPA Foundation for Education and Research on Botanicals (AHPA ERB Foundation) has committed to provide financial support for the American ginseng program to be presented as part of the 2020 Smithsonian Folklife Festival, an annual 10-day event that takes place on the National Mall in Washington, D.C. The Foundation is seeking matching funds from AHPA members to increase the Foundation’s support of this program.
AHPA-ABC-AHP HerbWalk at Expo East Tours Jim Duke's Green Farmacy Garden

AHPA-ABC-AHP HerbWalk at Expo East Tours Jim Duke's Green Farmacy Garden

Renowned herbalists to provide guided tour

Bus departs Baltimore Convention Center at 1:00 PM on Wednesday Sept. 11, 2019

July 2019 AHPA Report: McGuffin celebrates 20 years, CBD Advocacy, IADSA, AHPA in the News and more

AHPA Members, Log in to access the AHPA Report

The July 2019 AHPA Report includes an open letter from AHPA President Michael McGuffin on his 20 years as AHPA President, recent CBD advocacy, AHPA's recommendations for supplement innovation, AHPA email alerts and much more.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.

AHPA Hemp-CBD Status Report updated to cover recent FDA and USDA actions

Helping the herbal products industry understand the evolving regulatory landscape

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).
Michael McGuffin Celebrates 20 years as AHPA President

Michael McGuffin Celebrates 20 years as AHPA President

An Open Letter to the Membership

It is my heartfelt honor to address you today on the 20th anniversary of the date I began my role as President of the American Herbal Products Association. We have accomplished so much together since 1999!

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).
IADSA update on international supplement regulations

IADSA update on international supplement regulations

IADSA July 2019 Newsflash

China considers adding 5 functional ingredients, including reishi powder and spirulina, to its food raw materials directory, and changes to permitted health food function claims, in this issue of the IADSA Newsflash.

AHPA recommends FDA implement policies to support innovation

The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products.

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

RSS
12345678910 Last